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O B J E C T I V E S We sought to assess the association between the presence of a septal pouch in the
left atrium and ischemic stroke.
B A C KG ROUND It has been suggested that the presence of a left septal pouch (LSP) may favor the
stasis of blood and possibly result in thromboembolic complications. However, the embolic potential of
an LSP is not known.
METHOD S The association between an LSP and risk of stroke was assessed using a population-
based case-control study design. The presence of an LSP was assessed by transesophageal echocar-
diography in 187 patients 50 years of age with a ﬁrst-ever ischemic stroke (96 men, mean age 70.6 
9.0 years) and in 157 control subjects matched to patients by age, sex, and race/ethnicity. The
association between an LSP and risk of stroke was assessed after adjustment for other stroke risk factors.
R E S U L T S Patients with LSPs were younger than control subjects (67.5  9.1 years vs. 69.6  8.8
years; p  0.046), with a lower prevalence of hypertension (68.0% vs. 80.3%; p  0.01). There were no
differences in the prevalence of LSPs between stroke patients and control subjects (28.9% vs. 29.3%,
respectively; p  0.93). The subgroup of 69 patients (36.9%) with cryptogenic stroke showed a similar
prevalence of LSPs (31.9% vs. 29.3%; p  0.70). Multivariable analysis showed that the presence of an
LSP was not associated with ischemic stroke (odds ratio: 1.09; 95% conﬁdence interval: 0.64 to 1.85) or
cryptogenic stroke (odds ratio: 1.41; 95% conﬁdence interval: 0.71 to 2.78).
CONC L U S I O N S This study does not demonstrate evidence of the association of the presence of
an LSP with ischemic stroke or cryptogenic stroke. The stroke risk associated with LSPs requires further
evaluation in the younger stroke populations. The cofactors that may turn an LSP from an innocent
bystander to a causative mechanism for stroke remains to be elucidated. (J Am Coll Cardiol Img 2010;
3:1276–83) © 2010 by the American College of Cardiology Foundation
From the *Department of Medicine, Columbia University, New York, New York; †Department of Biostatistics, Columbia
University, New York, New York; ‡Department of Neurology and Epidemiology, Columbia University, New York, New York;
§Department of Neurology, University of Miami, Miami, Florida and the Department of Epidemiology and Human Genetics,
University of Miami, Miami, Florida. The study was supported by R01 NS36286 from the National Institute of Neurological
Disorders and Stroke (NINDS). Dr. Di Tullio was the recipient of a NINDS Mid-Career Award in Patient-Oriented Research
(K24 NS02241). All other authors have reported that they have no relationships to disclose.Manuscript received October 15, 2010; revised manuscript received October 27, 2010, accepted November 1, 2010.
T
t
T
(
p
t
(
c
i
r
s
f
s
t
o
T
h
s
(
i
e
s
t
e
s
p
e
a
i
l
s
t
h
l
L
t
p
c
a
b
i
s
t
L
M
S
o
t
p
f
b
p
s
n
U
e
n
m
I
T
a
d
u
p
S
s
o
I
c
n
I
U
D
C
t
i
H
b
a
m
a
s
t
o
u
l
t
p
C
t
d
p
b
c
a
a
i
i
c
ardiography
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 1 2 , 2 0 1 0
D E C E M B E R 2 0 1 0 : 1 2 7 6 – 8 3
Tugcu et al.
Atrial Septal Pouch and Stroke
1277he causes of ischemic stroke remain un-
identified by routine diagnostic testing in as
many as 40% of patients (1). These strokes,
often termed cryptogenic, have been linked to
he presence of atrial septal abnormalities (2–6).
he relationship between a patent foramen ovale
PFO) and cryptogenic stroke in younger stroke
atients has been confirmed in multiple studies with
ransthoracic or transesophageal echocardiography
TEE) (4,7–9). The association has been more
ontroversial in elderly subjects in whom it has been
nvoked or negated (4,10,11). Finally, a TEE study
eaffirmed the relationship between a PFO and
troke risk in an older age group after adjustment
or other stroke risk factors (12). The hypothesized
troke mechanism is paradoxical embolization or
he embolization to the systemic arterial circulation
f thrombus originating in the venous circulation.
he presence of an atrial septal aneurysm (ASA)
as also been associated with an increased risk of
troke, especially when it is associated with a PFO
13). In a meta-analysis, the stroke risk was higher
n subjects with a PFO plus ASA than in those with
ither condition alone (11,14).
The diagnosis of cryptogenic stroke remains pre-
umptive in a vast majority of patients and is based on
he exclusion of other potential causes of cerebral
mbolism in the setting of an embolic-appearing
troke rather than on the actual demonstration of
aradoxical embolization. Recently, a new anatomical
ntity, the left septal pouch (LSP), has been defined in
pathology study (15). An LSP was described as an
ncomplete fusion in the cranial segment of the over-
ap between the septum primum (SP) and septum
ecundum (SS), resulting in a recess that opens into
he left atrium, with no interatrial shunting. It was
ypothesized that, with access to the systemic circu-
ation similar to that of the left atrial appendage, an
SP might serve as a nidus for thrombus formation in
he presence of low flow states and therefore predis-
ose to embolic events. An LSP has anecdotally been
onsidered the culprit lesion for a transient ischemic
ttack and coronary embolus (16,17). An association
etween an LSP and stroke could provide novel
nsights into the mechanism of certain cryptogenic
trokes. The aim of the present study was, therefore,
o assess the existence of an association between an
SP and ischemic stroke.
E T H O D S
tudy population. As part of the National Institute
f Neurological Disorders and Stroke–funded Aor- hic Plaques and Risk of Ischemic Stroke study, 255
atients with acute ischemic stroke and 209 stroke-
ree control subjects were enrolled in the study
etween 1997 and 2002. The details of the study
opulation were previously described (18). Briefly,
troke patients were consecutive patients residing in
orthern Manhattan and admitted to Columbia
niversity Medical Center with a first acute isch-
mic stroke. All strokes were subtyped by a study
eurologist on the basis of pre-defined criteria
odeled after the Stroke Data Bank of the National
nstitute of Neurological Disorders and Stroke and
OAST (Trial of Organon in Acute Stroke Ther-
py) (19). Cryptogenic strokes typically had no
efinite source despite a thorough diagnostic eval-
ation. Control subjects were selected from the
articipants of NOMAS (Northern Manhattan
tudy) and matched to cases by age (within 5 years),
ex, and race/ethnicity. Detailed recruitment meth-
ds for NOMAS were previously reported (20,21).
nformed consent was obtained from cases and
ontrols, or their health proxies when
ecessary. The study was approved by the
nstitutional Review Board of Columbia
niversity Medical Center.
eﬁnition of baseline subject characteristics.
ardiovascular risk factors were ascer-
ained through direct examination and
nterview by trained research assistants.
ypertension was defined as a systolic
lood pressure recording 140 mm Hg or
diastolic blood pressure recording 90
m Hg based on the mean of 2 readings,
patient’s self-report of a history of hyperten-
ion, or antihypertensive medication use. Diabe-
es mellitus was defined by a patient’s self-report
f such a history, insulin use, oral hypoglycemic
se, or a fasting glucose 126 mg/dl. Hypercho-
esterolemia was defined as total serum choles-
erol 240 mg/dl, a patient’s self-report of hy-
ercholesterolemia, or lipid-lowering treatment.
urrent smoking was defined by use of tobacco at
he time of the interview; smoking history was
efined by use of tobacco at any time. The
resence of atrial fibrillation was documented
ased on the results of a current or past electro-
ardiogram. Coronary artery disease was defined
s a history of myocardial infarction, coronary
rtery bypass grafting or percutaneous coronary
ntervention, typical angina, and use of anti-
schemic medications. Body mass index was
alculated as weight (kilograms) divided by
A B B
A N D
ASA
CI c
LSP
OR
PFO
TEE
echoceight (meters) squared. Race/ethnicity waR E V I A T I O N S
A C R O N YM S
atrial septal aneurysm
onfidence interval
left septal pouch
odds ratio
patent foramen ovale
transesophageals de-
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1278ermined by subject’s self-report using a ques-
ionnaire modeled after the U.S. Census Bureau
uestionnaire.
EE evaluation. TEE was performed in stroke pa-
ients within 3 days of stroke onset and in control
ubjects on enrollment. A pre-defined protocol was
sed to assess for potential cardiac and aortic
ources of embolism, including the assessment for
he presence of a PFO at rest and during Valsalva
aneuver using a multiplane transducer and agi-
ated saline injection. After careful observation of
he interatrial septum using 2-dimensional echocar-
iography and color Doppler mapping of the sep-
um with the Valsalva maneuver, 2 intravenous
ontrast injections were administered through the
ight antecubital vein at rest and with the Valsalva
aneuver. PFO was considered to be present if any
icrobubble was seen in the left atrium within 3
ardiac cycles from maximum right atrial opacifica-
ion (2–4). An ASA was defined as more than a
0-mm protrusion beyond the plane of the septum
nto the left or right atrium (22). For the purpose of
he present study, TEE was systematically reviewed
or LSP presence. An LSP was defined as an
ncomplete fusion in the cranial segment of the
verlap between the SP and SS in a standard bicaval
iew (Fig. 1A), with no evidence of right-to-left
hunting on contrast injection at rest or during the
alsalva maneuver (Fig. 1B). The presence of a
ight septal pouch (incomplete septal fusion in the
audal segment of the septum with opening into the
ight atrium) or of a closed pouch (incomplete
usion of the septum without opening into either
Figure 1. An Example of LSP Demonstrated by TEE
(A) Direct visualization of a left septal pouch (LSP) (arrow) by trans
incomplete fusion is visible in the cranial segment of the zone of o
(SS). (B) Differentiation of an LSP from a patent foramen ovale by c
maneuver demonstrates the absence of microbubbles crossing the
LA  left atrium; RA  right atrium.trial chamber) was recorded. TEE studies were
nterpreted by 2 experienced echocardiography fellows
A.T., K.O.) blinded to subjects’ case-control status,
linical characteristics, and stroke risk factors.
nterobserver variability. Twenty randomly chosen
EE studies were read by both observers indepen-
ently for the presence or absence of an LSP. There
as 100% agreement between the 2 observers (95%
onfidence interval [CI]: 86.7% to 100.0%).
tatistical analysis. Data are presented as mean 
D for continuous variables and as proportions for
ategorical variables. Differences between propor-
ions were assessed by the chi-square test and
eplaced by the Fisher exact test when the expected
ell count was5. Differences between mean values
ere assessed by the Student t test.
Univariable and multivariable logistic regression
nalysis was carried out to assess the association
etween an LSP (independent variable) and isch-
mic stroke (dependent variable). Variables signifi-
antly associated with ischemic stroke at univariable
nalysis (arterial hypertension, diabetes mellitus,
ypercholesterolemia, smoking history, and atrial
brillation) were entered as independent variables
n the model, along with pertinent demographics
age, sex). The C statistic (equivalent to the area
nder the receiver-operator characteristic curve)
as calculated to assess the performance of the
ogistic model.
SAS software (version 9.2, SAS Institute, Cary,
orth Carolina) was used in the analyses. A
-tailed p value of0.05 was considered significant
or all analyses.
hageal echocardiography (TEE). In the longitudinal plane, an
p between the septum primum (SP) and the septum secundum
ast TEE. Injection of agitated contrast saline with a Valsalva
ratrial septum, excluding the presence of a patent foramen ovale.esop
verla
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1279E S U L T S
f the initial 464 subjects, 107 were excluded from
he analysis because of the presence of a PFO (n 
9), a closed pouch (n  9), a right septal pouch
n  5), or an atrial septal defect (n  4). Another
3 patients were excluded from the analyses because
f a technically inadequate echocardiographic con-
rast study. The analyses were performed in the
emaining 344 subjects.
aseline characteristics. The final study population
as composed of 187 stroke patients and 157
troke-free subjects. The cause of stroke could be
dentified by means of routine diagnostic testing in
18 patients (63.1%). The stroke was classified as
ryptogenic in the remaining 69 patients (36.9%).
n LSP was detected in 100 subjects (29.1%); an
SA was found in 16 (4.7%).
omparison of cases and controls. Demographics,
ardiovascular risk factors, and atrial septal abnor-
alities in stroke patients and in control subjects
re shown in Table 1. Stroke patients were signif-
cantly older than control subjects (70.6  9.0 years
s. 67.0  8.4 years; p  0.0002) and had a
ignificantly higher prevalence of hypertension and
iabetes (both p  0.0001). A history of atrial
brillation was also more frequent in stroke patients
han in control subjects (p  0.02). The frequency
f hypercholesterolemia was significantly lower in
he stroke group (p  0.045). There were no
ifferences with regard to the prevalence of LSPs
nd ASAs in stroke patients compared with control
ubjects (28.9% vs. 29.3%; p  0.93; and 5.9% vs.
.2%; p  0.24, respectively).
omparison of patients with and without an LSP.
haracteristics of subjects with and without an LSP
re summarized in Table 2. Patients with LSPs
ere younger (67.5 9.1 years vs. 69.6 8.8 years;
 0.046) and had a lower frequency of hyperten-
ion (68.0% vs. 80.3%; p 0.01). The prevalence of
SAs did not differ between subjects with or
ithout LSPs (4.0% vs. 5.0%; p  0.71). Other
emographic features and traditional risk factors
ere not significantly different between the 2
roups.
ssociation between an LSP and ischemic stroke. The
ubgroup of patients with cryptogenic stroke was
ompared with control subjects (Table 3). Crypto-
enic stroke patients were on average 2 years older
nd had a higher prevalence of hypertension (79.7%
s. 66.9%; p  0.05) and diabetes mellitus (37.7%
s. 22.9%; p  0.02), and a lower prevalence of
ypercholesterolemia (35.8% vs. 53.5%, p  0.02).here was no difference with regard to the preva-
ence of LSPs and ASAs between the 2 groups.
The presence of an LSP was not found to be
ssociated with an increased risk of ischemic stroke,
ither at univariable analysis (OR: 0.98; 95% CI:
.61 to 1.56) or after adjustment for other stroke
isk factors (OR: 1.09; 95% CI: 0.64 to 1.85) (Table 4).
he presence of an LSP was also not found to be
ssociated with an increased risk of cryptogenic
troke (Table 5).
I S C U S S I O N
his study does not demonstrate evidence of an
ssociation of the presence of an LSP with ischemic
troke. The lack of an association was also observed
n a subgroup analysis of cryptogenic stroke cases in
hich the effect of new cardioembolic sources could
e more relevant. Our results do not support the
ypothesis that embolism from an LSP is a cause of
schemic stroke, even among patients without an-
ther apparent mechanism of cerebral ischemia.
The left atrium is a potential source of systemic
mbolization. Thrombus formation in the left
trium and its appendage in patients with atrial
Table 1. Demographics, Risk Factors, and LSP Frequency Status
Control Subjects
Stroke Patients
(n  187)
Control Su
(n  15
Age, yrs 70.6 9.0 67.0 8
60 21 (11) 30 (19
60–69 69 (37) 70 (45
70 97 (52) 57 (36
Male 96 (51.3) 88 (56
Body mass index, kg/m2 26.7 5.1 27.6 4
Race/ethnicity
White 28 (15.0) 23 (14
Black 52 (27.8) 50 (31
Hispanic 107 (57.2) 84 (53
Risk factors
Hypertension 158 (85.0) 105 (66
Diabetes mellitus 86 (46.5) 36 (22
Hypercholesterolemia 78 (42.6) 84 (53
Current smoker 33 (18.3) 25 (16
Smoking history 103 (55.7) 99 (63
Coronary artery disease 36 (19.4) 33 (21
Atrial ﬁbrillation 22 (11.8) 7 (4.5
Atrial septal abnormalities
ASA 11 (5.9) 5 (3.2
LSP 54 (28.9) 46 (29
Values are mean  SD or n (%).in Stroke and
bjects
7) p Value
.4 0.0002
)
) 0.009
)
.0) 0.38
.8 0.09
.7)
.9) 0.71
.5)
.9) 0.0001
.9) 0.0001
.5) 0.045
.2) 0.61
.1) 0.17
.0) 0.70
) 0.02
) 0.24
.3) 0.93ASA  atrial septal aneurysm; LSP  left septal pouch.
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1280brillation and the consequent thromboembolic
isk is well known (23–26). The pathogenesis of
ryptogenic stroke in patients with interatrial septal
bnormalities is not well understood. The morpho-
ogic characteristics of the interatrial septum that
est predict the risk of thromboembolism remain
nclear. It has long been debated whether the
resence of a PFO actually plays a causal role in
troke or whether there is only a noncausal statis-
ical relationship. Although there is considerable
vidence that a PFO can cause ischemic stroke by
eans of paradoxical embolism, the difficulty of
onfirming the occurrence of embolism has led to
he consideration of alternative explanations such as
n situ thrombosis or atrial tachyarrhythmia (22,27).
he former, however, is very rarely found by TEE
r at autopsy. Although patients with interatrial
bnormalities and stroke have lower thresholds for
he induction of atrial fibrillation, this arrhythmia is
arely documented in patients with cryptogenic
troke and a PFO (27,28). Moreover, in patients
ith a cryptogenic stroke, approximately one third
f discovered PFOs are likely to be incidental (29).
inally, the association between a PFO and stroke
n the general population was not supported by 2
ajor studies (30,31). Therefore, there is an exten-
ive ongoing search for other plausible mechanisms
hat may explain the origin of cryptogenic ischemic
cs and Risk Factors by LSP Status
LSP ()
(n  100)
LSP ()
(n  244) p Value
67.5 9.1 69.6 8.8 0.046
22 (22) 29 (12)
39 (39) 100 (41) 0.050
39 (39) 115 (47)
57 (57.0) 127 (52.0) 0.40
2 27.0 4.8 27.1 5.1 0.88
10 (10.0) 41 (16.8)
28 (28.0) 74 (30.3) 0.18
62 (62.0) 129 (52.9)
68 (68.0) 195 (80.3) 0.01
42 (42.0) 80 (33.1) 0.12
ia 45 (45.0) 117 (48.8) 0.53
12 (12.5) 46 (19.3) 0.14
63 (63.6) 139 (57.2) 0.27
ase 15 (15.0) 54 (22.2) 0.13
10 (10.0) 19 (7.9) 0.52
n (%).trokes. tAn LSP was first described by Krishnan and
alazar (15) as a new anatomical entity with poten-
ial embolic complications. It was suggested that
his pouchlike structure may favor the stagnation of
lood, with consequent risk of thrombus formation
nd thromboembolic complications. In their study,
he prevalence of an LSP was 39%, which is
onsiderably higher than the prevalence of PFO in
he general population (24%) (31). This observation
ight have great practical importance because evi-
ence linking such a frequent entity to ischemic
troke could provide additional insights into the
echanisms of cryptogenic stroke.
After the exclusion of subjects with a PFO, an
SP was present in 29.1% of the subjects in our
tudy, a prevalence that is lower compared with that
n the previous study. Our patient population was
onsiderably older (69  9 years of age vs. 50  21
ears of age), and, similar to a PFO, the prevalence
f an LSP might decrease with advancing age (32).
n fact, subjects with an LSP tended to be signifi-
antly younger than subjects without an LSP, sup-
orting this hypothesis. An LSP showed an equal
istribution across sex, race-ethnic subgroups, and
raditional risk factors analyzed, except for hyper-
ension. Subjects without an LSP had a significantly
igher prevalence of hypertension. One hypothesis
egarding the lower frequency of LSPs in hyperten-
ive subjects may be that an increased left atrial
ressure might force the SP against the SS and
avor the fusion between these 2 septal components.
We observed that the prevalence of LSPs was not
ignificantly different between stroke patients and
ontrol subjects (28.9% vs. 29.3%). Given the
ften-discussed association of a PFO and crypto-
enic stroke, we also undertook a subgroup analysis
or patients with cryptogenic stroke, which also
howed that the prevalence of LSPs did not differ
etween cryptogenic stroke patients and control
ubjects (32.4% vs. 29.8%). Both univariable and
ultivariable analyses revealed that an LSP did not
ave any impact on either ischemic (adjusted OR:
.09; 95% CI: 0.64 to 1.85) or cryptogenic (adjusted
R: 1.41; 95% CI: 0.71 to 2.78) stroke. These
ndings suggest that an LSP is more likely an
nnocent bystander than a potential thrombo-
enic source. However, our results may not ex-
lude the possibility that in the presence of
ssociated cofactors, such as hypercoagulability,
n LSP may favor thrombus formation and there-
ore cerebral embolization.
tudy limitations. This case-control study is the firstTable 2. Demographi
Age, yrs
60
60–69
70
Male
Body mass index, kg/m
Race/ethnicity
White
Black
Hispanic
Risk factors
Hypertension
Diabetes mellitus
Hypercholesterolem
Current smoker
Smoking history
Coronary artery dise
Atrial ﬁbrillation
Values are mean  SD oro date that assessed the role of an LSP as a stroke
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1281isk factor. The interpretation of echocardiograms
as blinded to the subjects’ characteristics and risk
actors, eliminating the possibility of ascertainment
ias. The main limitation of our study is the
elatively small sample size, which may have af-
ected the statistical power to detect a significant
isk associated with an LSP. However, with the
bserved OR of 0.98 (resulting from a 28.9% pouch
revalence rate in stroke patients and a 29.3%
ouch prevalence rate in control subjects), a total of
0,400 subjects (1:1 ratio for case vs. control) would
Table 3. Demographics, Risk Factors, and LSP Frequency in Cry
Cryptogenic Stroke P
(n  69)
Age, yrs 69.7 8.4
60 10 (14)
60–69 26 (38)
70 33 (48)
Male 35 (50.7)
Body mass index, kg/m2 27.2 5.2
Race/ethnicity
White 9 (13.0)
Black 23 (33.3)
Hispanic 37 (53.6)
Risk factors
Hypertension 55 (79.7)
Diabetes mellitus 26 (37.7)
Hypercholesterolemia 24 (35.8)
Current smoker 13 (20.0)
Smoking history 38 (55.9)
Coronary artery disease 10 (14.5)
Atrial ﬁbrillation 3 (4.4)
Atrial septal abnormalities
ASA 5 (7.3)
LSP 22 (31.9)
Values are mean  SD or n (%).
Abbreviations as in Table 1.
Table 4. Predictors of Ischemic Stroke
Univariable Mod
OR (95% CI)
Age* 1.05 (1.02–1.08)
Male 0.83 (0.54–1.27)
Diabetes mellitus 2.92 (1.82–4.68)
Hypertension 2.79 (1.66–4.71)
Hypercholesterolemia 0.65 (0.42–0.99)
Smoking history 0.74 (0.48–1.14)
Atrial ﬁbrillation 2.86 (1.19–6.88)
LSP 0.98 (0.61–1.56)
*Age as a continuous variable. Univariable model for LSP: chi-square 0.007, de
45.9, degrees of freedom  8, p  0.0001, C statistic  0.73.
CI  conﬁdence interval; LSP  left septal pouch; OR  odds ratio.e needed to detect a significant difference with
0% power at the 0.1 significance level. The match-
ng of cases and controls was inadequate to control
or differences by age. However, age was entered as
potential confounder in all multivariable analyses.
s in other case-control studies, our study has the
imitation of possibly unequal distribution of prog-
ostic variables between cases and controls, which
ay not have been completely adjusted for in the
nalysis. Because of the relatively advanced mean
ge of the population, we could not compare
enic Stroke and Control Subjects
nts Control Subjects
(n  157) p Value
67.0 8.4 0.03
30 (19)
70 (45) 0.26
57 (36)
88 (56.1) 0.46
27.6 4.8 0.55
23 (14.7)
50 (31.9) 0.94
84 (53.5)
105 (66.9) 0.05
36 (22.9) 0.02
84 (53.5) 0.02
25 (16.2) 0.50
99 (63.1) 0.31
33 (21.0) 0.25
7 (4.5) 0.96
5 (3.2) 0.18
47 (29.3) 0.70
Multivariable Model
p Value OR (95% CI) p Value
0.0002 1.05 (1.02–1.08) 0.0006
0.383 1.14 (0.70–1.86) 0.60
0.0001 3.47 (2.06–5.86) 0.0001
0.0001 2.53 (1.41–4.53) 0.002
0.046 0.60 (0.37–0.96) 0.03
0.17 0.72 (0.44–1.16) 0.18
0.02 2.18 (0.83–5.74) 0.12
0.93 1.09 (0.64–1.85) 0.76
of freedom 1, p 0.93, C statistic 0.50; multivariable model: chi-squareptog
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1282ifferent age groups (younger vs. older). Therefore,
ur results should not be extrapolated to a younger
atient population.
O N C L U S I O N S
ur results show no evidence of an association
etween the presence of an LSP and ischemic
troke. The possibility that the stroke risk may be
ncreased in a subgroup of younger subjects with
Table 5. Predictors of Cryptogenic Stroke
Univariable Mod
OR (95% CI)
Age* 1.04 (1.00–1.07)
Male 0.81 (0.46–1.42)
Diabetes mellitus 2.03 (1.10–3.75)
Hypertension 1.95 (0.99–3.82)
Hypercholesterolemia 0.49 (0.27–0.88)
Smoking history 0.74 (0.42–1.32)
Atrial ﬁbrillation 0.97 (0.24–3.86)
LSP 1.13 (0.61–2.08)
*Age as a continuous variable. Univariable model for LSP: chi-square  0.15, deg
17.45, degrees of freedom  7, p  0.03, C statistic  0.69.
Abbreviations as in Tables 1 and 4.genic stroke in patients less than 55
years of age. A study using trans- R, Gomez CR, Lossible associated cofactors that may turn an LSP
rom an innocent bystander into a causative mech-
nism for stroke remain to be elucidated.
cknowledgments
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Multivariable Model
p Value OR (95% CI) p Value
0.03 1.04 (1.00–1.08) 0.03
0.46 1.06 (0.56–2.01) 0.86
0.02 2.25 (1.14–4.44) 0.02
0.053 1.98 (0.94–4.16) 0.07
0.02 0.50(0.27–0.93) 0.03
0.31 0.73(0.39–1.38) 0.34
0.96 0.48 (0.09–2.70) 0.41
0.70 1.41 (0.71–2.78) 0.33
of freedom 1, p  0.70, C statistic  0.51; multivariable model: chi-square LSPs cannot be excluded by this study. Also, E-mail: md42@columbia.edu.1
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